SCHEMBL4466653

SCHEMBL4466653

O=C(O)c1nc2cc(OCc3ccccc3)ccc2[nH]1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.61
HPGD P15428 2/20 0.61
KDM4E B2RXH2 1/20 0.61
CYP1A2 P05177 1/20 0.61
CYP2C9 P11712 1/20 0.61
SRD5A2 P31213 1/20 0.61
HSD17B10 Q99714 1/20 0.61
PDGFRB P09619 1/20 0.54
PDGFRA P16234 1/20 0.54
RHEB Q15382 1/20 0.54
FAAH O00519 1/20 0.53
CYP3A4 P08684 1/20 0.50
NR4A2 P43354 2/20 0.49
NR4A1 P22736 1/20 0.49
NR4A3 Q92570 1/20 0.49
FLT3 P36888 1/20 0.48
P4HTM Q9NXG6 1/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
ALOX5 P09917 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2131850 0.90 KDM4E (0.55) ALDH1A1HPGDKDM4ECYP1A2CYP2C9
SCHEMBL4470392 0.80 NPC1 (0.52) ALDH1A1HPGDKDM4ECYP1A2CYP2C9
SCHEMBL2131853 0.80 XDH (0.55) ALDH1A1HPGDKDM4ECYP1A2CYP2C9
SCHEMBL4825992 0.80 CYP3A4 (0.54) ALDH1A1HPGDKDM4ECYP1A2CYP2C9
SCHEMBL9529962 0.80 CYP3A4 (0.54) ALDH1A1HPGDKDM4ECYP1A2CYP2C9
SCHEMBL28021757 0.78 LMNA (0.57) ALDH1A1HPGDKDM4ECYP1A2CYP2C9
SCHEMBL2133843 0.78 MAOB (0.59) FAAHNR4A2MAOAMAOB
SCHEMBL2132114 0.78 FFAR1 (0.45) ALDH1A1HPGDKDM4ECYP1A2CYP2C9
SCHEMBL4826512 0.77 EGLN1 (0.53) ALDH1A1HPGDKDM4ECYP1A2CYP2C9
SCHEMBL5579690 0.77 CHEK2 (0.59) ALDH1A1HPGDKDM4ECYP1A2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115427035-B ENL/AF9 YEATS inhibitors 洛克菲勒大学 2025-04-22 CN disclosed
US-20230027198-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY 2023-01-26 US disclosed
US-20230027198-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY 2023-01-26 US disclosed
CN-115427035-A ENL/AF9YEATS inhibitors 洛克菲勒大学 2022-12-02 CN disclosed
EP-4076440-A1 INHIBITORS OF ENL/AF9 YEATS The Rockefeller University (US) 2022-10-26 EP disclosed
WO-2021127166-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY (US) 2021-06-24 WO disclosed
WO-2021127166-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY (US) 2021-06-24 WO disclosed
US-7531668-B2 2-arylcarboxamide-nitrogenous heterocycle compound BANYU PHARMACEUTICAL CO., LTD. (JP) 2009-05-12 US disclosed
US-20070299070-A1 2-Arylcarboxamide-Nitrogenous Heterocycle Compound MSD K.K. (JP) 2007-12-27 US disclosed
EP-1798221-A1 2-ARYLCARBOXAMIDE-NITROGENEOUS HETEROCYCLE COMPOUND BANYU PHARMACEUTICAL CO., LTD. (JP) 2007-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230027198-A1 INHIBITORS OF ENL/AF9 YEATS MLLT3, YEATS2, MLLT1 ALDH1A1 2425/4885HPGD 3998/4885KDM4E 84/4885
US-20070299070-A1 2-Arylcarboxamide-Nitrogenous Heterocycle Compound MCHR2, MCHR1, NPY2R ALDH1A1 1060/4885HPGD 1342/4885KDM4E 2454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.